Ventyx Biosciences Inc (VTYX) recent quarterly performance of 281.36% is not showing the real picture

Steve Mayer

As on Wednesday, Ventyx Biosciences Inc (NASDAQ: VTYX) got off with the flyer as it spiked 11.25% to $9.0, before settling in for the price of $8.09 at the close. Taking a more long-term approach, VTYX posted a 52-week range of $0.78-$9.50.

The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded -87.13%. Meanwhile, its Annual Earning per share during the time was -87.13%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 15.55%. This publicly-traded company’s shares outstanding now amounts to $71.23 million, simultaneously with a float of $63.62 million. The organization now has a market capitalization sitting at $641.78 million. At the time of writing, stock’s 50-day Moving Average stood at $3.95, while the 200-day Moving Average is $2.42.

Ventyx Biosciences Inc (VTYX) Ownership Facts and Figures

Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Ventyx Biosciences Inc’s current insider ownership accounts for 10.79%, in contrast to 63.18% institutional ownership. According to the most recent insider trade that took place on Apr 02 ’25, this organization’s CHIEF SCIENTIFIC OFFICER sold 1,887 shares at the rate of 1.07, making the entire transaction reach 2,019 in total value, affecting insider ownership by 467,226. Preceding that transaction, on Dec 27 ’24, Company’s CHIEF SCIENTIFIC OFFICER sold 21,119 for 2.36, making the whole transaction’s value amount to 49,841. This particular insider is now the holder of 464,582 in total.

Ventyx Biosciences Inc (VTYX) Earnings and Revenue Records

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.45 per share during the current fiscal year.

Ventyx Biosciences Inc’s EPS increase for this current 12-month fiscal period is 15.55% and is forecasted to reach -1.92 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -1.06% through the next 5 years, which can be compared against the -87.13% growth it accomplished over the previous five years trading on the market.

Ventyx Biosciences Inc (NASDAQ: VTYX) Trading Performance Indicators

Let’s observe the current performance indicators for Ventyx Biosciences Inc (VTYX). It’s Quick Ratio in the last reported quarter now stands at 19.12.

In the same vein, VTYX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.68, a figure that is expected to reach -0.45 in the next quarter, and analysts are predicting that it will be -1.92 at the market close of one year from today.

Technical Analysis of Ventyx Biosciences Inc (VTYX)

Through scrutinizing the latest numbers posted by the [Ventyx Biosciences Inc, VTYX], it can be observed that its last 5-days Average volume of 3.95 million was better the volume of 2.13 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 76.12% While, its Average True Range was 81.29.

Raw Stochastic average of Ventyx Biosciences Inc (VTYX) in the period of the previous 100 days is set at 93.38%, which indicates a major rise in contrast to 91.79% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.84 that was higher than 0.31 volatility it exhibited in the past 100-days period.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.